Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences in September:

• The Janney Healthcare Conference 2019 on Monday, September 9^th in New York City. Management will present at 8:15 a.m. ET and will also participate in investor meetings.
   
• The H.C. Wainwright 21^st Annual Global Investment Conference on Tuesday, September 10^th in New York City. Management will present at 11:15 a.m. ET and will also participate in investor meetings.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.

Contact:
Alex Dasalla
[email protected]

You May Also Be Interested In

• MoonRush Launches Social Trading App Combining On-Chain Market Discovery and AI-Powered Risk Protection
• Collegium Pharma (COLL) 2700 contracts of August 39 calls trade
• Manhattan 24 Hour Live-In Care Swaps Fear for Peace of Mind at Touching Hearts at Home NYC